← Eichor
Study identifier: NCT06483620 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire

Condition: Diabetic Neuropathies · Diabetic Peripheral Neuropathy  ·  Sponsor: Cairo University

PhaseN/A
Planned participants290
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

PURPOSE: This study will translate, culturally adapt, validate, and test the reliability of the Neuro Qol Arabic version to be used with diabetic patients in Arabic countries. Background: The Neuropathy- and Foot Ulcer-Specific Quality of Life instrument is a multidimensional scale was developed to assess the QoL of diabetic patients with peripheral neuropathy. Producing Arabic versions of the Translating Scale can help researchers investigate offloading treatment among the Arabic population with DFUs. Hypotheses: The study design was a cross-cultural validation of NeuroQol, the Arabic version, for patients with DFUs. Research Question: Will there be cultural adaptation, validation, and reliability between the (Neuro Qol) Arabic version and the original language?

This description comes directly from the study's public registry record.

Talk to the study team

Engy BadrEldin S Moustafa, PhD  ·  00201099445112  ·  engybm.saleh@cu.edu.eg

Shimaa T. AbulKasem, PhD  ·  00201229823327  ·  dr.shymaelshazly@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Faculty of Physical Therapy, Cairo UniversityCairo, Giza Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06483620